Merit Medical Systems, Inc. MMSI 深 滬
等待開盤 08-10 09:30:00 美东时间
89.04
+1.350
+1.54%
華盛通- 最 高89.265
- 今 開88.09
- 成交量 109.70万股
- 最 低 87.47
- 昨 收 87.69
- 總市值 531.66万
- 52周最高 94.7482
- 市盈率 靜 41.90
- 換手率 1837.22%
- 52周最低 59.74
- 委 比 61.08%
- 總股本 5.97万
- 歷史最高 111.45
- 量 比 0.65
- 振 幅 2.05%
- 歷史最低 9.15
- 每 手 1
- 風險率 8.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Merit Medical to Participate in Upcoming Investors Conferences in August
Merit Medical Systems announced that its management will participate in two upcoming investor conferences: the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11-13, 2026, with a fireside chat on August 11 at 11:00 a.m. ET, and the Bank of America SMID Cap Conference virtually on August 11-12, 2026, with a fireside chat on August 12 at 9:00 a.m. ET. Live audio webcasts and replays will be available on the Company’s investor re...
08-05 16:00
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
美股大行评级 | 最高400美元！亚马逊绩后获11家大行上调目标价；苹果绩后评级分歧大！3家上调，3家下调；德康医疗、万事达、神经分泌生物科学获多家大行上调目标价
今日重点评级关注：TD Cowen：维持加拿大鹅"买入"评级，目标价从13美元升至18美元；瑞银：维持吉登运动服"买入"评级，目标价从110美元升至111美元
08-03 11:38
Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $101
Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $90 to $101.
07-31 17:56
Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 Est; Raises FY2026 Sales Guidance from $1.612B-$1.634B to $1.631B-$1.643B vs $1.620B Est
Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 analyst estimate. Raises FY2026 sales outlook from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion vs $1.620 billion estimate.
07-31 04:09
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
Merit Medical Systems announced it will release its Q2 2026 financial results on July 30, 2026, followed by an investor conference call at 4:30 p.m. ET. Pre-registration for the call is required via the provided link, and a live webcast will also be available. Founded in 1987, Merit is a global leader in healthcare technology, specializing in medical devices for various medical fields with over 7,500 employees worldwide.
07-02 20:05
行业挑战背景下Merit Medical Systems及医疗设备类股一季度表现跑赢大盘
美利德医疗系统（纳斯达克代码：MMSI）发布202X年一季度财报，核心经营数据如下： - 一季度营收3.819亿美元，同比增长7.5%，较分析师预期高出1.2...
06-26 06:08
美股大行评级 | 苹果获多家机构上调目标价，最高至335美元；闪迪获华尔街大行看多至2000美元
今日重点评级关注：Benchmark：维持史密斯微软件"买入"评级，目标价从2美元升至2.5美元；Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元
05-04 16:04
Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $90
Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $101 to $90.
05-01 18:35
